Equities

Monogram Technologies Inc

Monogram Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.07
  • Today's Change-0.06 / -2.82%
  • Shares traded34.35k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.

  • Revenue in USD (TTM)365.00k
  • Net income in USD-13.39m
  • Incorporated2016
  • Employees28.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Heartbeam Inc0.00-15.11m54.50m15.00--4.35-----0.6111-0.61110.000.47620.00----0.00-200.17---258.74--------------0.00-------12.94------
Apyx Medical Corp50.45m-22.81m55.43m252.00--2.74--1.10-0.6583-0.65831.460.58460.79141.774.49200,202.40-35.94-25.24-46.73-29.9763.7066.11-45.41-46.004.94-9.210.6207--17.6125.8219.28--7.99--
Alpha Pro Tech, Ltd.60.92m4.21m56.22m124.0013.380.887410.940.9230.35960.35965.225.420.89081.688.21491,250.006.1615.216.3316.0638.1940.236.9212.9315.31--0.000.00-1.215.6027.642.935.50--
DarioHealth Corp19.04m-59.90m56.37m276.00--0.7168--2.96-2.04-2.040.6332.650.15552.343.5769,000.00-43.90-73.26-51.33-87.5927.5629.54-282.38-293.542.67--0.2673---26.4122.450.5091--52.42--
InspireMD Inc6.21m-19.92m57.34m65.00--1.27--9.24-1.08-1.080.25651.810.17172.364.3795,461.54-55.10-60.59-65.08-72.9729.1220.46-320.97-334.786.99--0.00--20.0011.50-7.71--41.57--
Medinotec Inc3.05m-566.90k58.67m29.00--28.27--19.24-0.0483-0.04830.25980.17690.67122.0616.96105,130.70-12.48---13.23--53.56---18.59--8.571.440.4323---3.91---184.47------
Envoy Medical Inc316.00k-29.91m60.96m34.00------192.90-2.60-2.600.0207-0.0899------9,294.12---------149.68---9,464.56--0.8169-266.25----33.33---87.83------
Beyond Air Inc689.00k-66.70m62.88m98.00--2.34--91.26-2.13-2.130.02190.58670.0111.441.247,030.61-112.64-70.88-148.49-88.69-115.24---10,288.68-1,530.313.26--0.382-------29.27------
Hyperfine Inc11.69m-41.93m64.31m131.00--0.8502--5.50-0.5858-0.58580.16331.050.11271.032.8089,251.91-40.40---43.95--42.39---358.59--8.26------61.90--39.54------
Monogram Technologies Inc365.00k-13.39m65.56m28.00------179.61-0.4414-0.44140.012--0.0316----13,035.71-115.81-119.26-226.52-257.400.00---3,669.37-5,045.60----0.00-------0.3964---15.97--
DIH Holding US Inc60.30m-1.77m65.68m--------1.09-0.0435-0.04351.49-0.8079----------------60.18---2.93--0.26561.50----12.15--80.41------
Pro-Dex Inc48.24m5.00m66.67m146.0014.022.1711.031.381.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Asensus Surgical Inc8.72m-78.71m70.80m207.00--5.43--8.12-0.3065-0.30650.03390.04790.12711.7913.0942,144.93-114.63-71.10-146.89-79.04-52.04-71.39-902.25-1,207.710.689--0.00--21.02-18.67-3.80---6.14--
Vivos Inc18.00k-3.20m71.58m10.00--53.35--3,976.92-0.0087-0.00870.000050.00340.0127--3.13---225.38-202.25-235.64-552.77-33.3310.79-17,805.45-11,969.07----0.00---46.58---17.19------
Neuronetics Inc73.23m-27.54m78.29m202.00--2.83--1.07-0.9484-0.94842.520.92260.70612.265.43360,714.30-26.56-28.02-30.98-34.7375.5275.73-37.61-51.045.18-4.270.6825--9.426.2218.76--18.57--
Data as of May 17 2024. Currency figures normalised to Monogram Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

0.47%Per cent of shares held by top holders
HolderShares% Held
Renaissance Technologies LLCas of 31 Dec 202332.30k0.10%
New Harbor Financial Group LLCas of 31 Mar 202429.35k0.09%
Geode Capital Management LLCas of 31 Dec 202315.37k0.05%
Commonwealth Equity Services LLCas of 31 Mar 202415.32k0.05%
Millennium Management LLCas of 31 Dec 202313.28k0.04%
Susquehanna Financial Group LLLPas of 31 Mar 202412.06k0.04%
OneDigital Investment Advisors LLCas of 31 Mar 202410.67k0.03%
JPMorgan Securities LLC (Investment Management)as of 31 Mar 20247.55k0.02%
Wells Fargo Clearing Services LLCas of 31 Mar 20246.00k0.02%
BlackRock Fund Advisorsas of 31 Mar 20244.75k0.02%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.